Ladenburg Thalmann Financial Services’s Xtant Medical Holdings XTNT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Buy	+25	New	+$51	﹤0.01%	5522

Other funds holding XTNT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Ladenburg Thalmann Financial Services's XTNT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Xtant Medical Holdings (XTNT) in Q4 2019: 25 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #5522 among its holdings.

15 funds tracked by Wall St. Rank hold XTNT as of Q4 2019.

Ladenburg Thalmann Financial Services held 25 shares of Xtant Medical Holdings worth $0 as of Q4 2019.
Xtant Medical Holdings was a new Ladenburg Thalmann Financial Services position in Q4 2019.
Xtant Medical Holdings made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5522 holding.
15 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.